AUS
NZ
UK
CA
USA
IND
Hazer Group Limited (ASX:HZR), an Australian company specializing in hydrogen and graphite technologies, has informed the market that 244,080 unquoted options have lapsed after the conditions tied to these securities were not fulfilled or became impossible to satisfy by 30 June 2026. These lapsed options, traded under the code HZRAE, have been officially removed from Hazer’s Capital/">Issued Capital as per a company update filed on 1 July 2026. Following this lapse, the total number of unquoted HZRAE options outstanding stands at 24,049,941, while the count of ordinary fully paid shares remains at 267,847,838. This development reflects a slight decrease in the company’s outstanding option obligations, relevant for investors monitoring Hazer’s capital structure and potential dilution.
Key Points
- Company: Hazer Group Limited (ASX:HZR)
- 244,080 unquoted HZRAE options have expired following unmet conditions as of 30 June 2026
- Options lapsed because attached conditions were not met or became unsatisfiable
- No payment was made by Hazer for the cessation of these options
- Remaining HZRAE options: 24,049,941; ordinary fully paid shares: 267,847,838
- Investors should monitor further capital structure changes and progress in Hazer’s hydrogen technology commercialisation
244,080 HZRAE Options Expire Due to Unfulfilled Conditions at 30 June 2026
Hazer Group Limited has officially notified the market that 244,080 options under the ASX code HZRAE ceased as of 30 June 2026. This was confirmed in an Appendix 3H filing lodged on 1 July 2026, which stated that the options lapsed because the conditions attached to them were either unmet or became impossible to satisfy before their expiry.
These options are typically issued as part of employee incentive or performance-based remuneration schemes, requiring vesting or performance criteria to be met within specified periods. When such conditions fail to be achieved, the options expire without value transfer to holders and without diluting existing shareholders. Hazer confirmed no consideration was paid for this lapse, consistent with standard practice for conditional option expiries.
Role of the HZRAE Option Class in Hazer’s Capital Structure
The HZRAE options are described as "expiring on various dates, exercisable at various prices," indicating multiple tranches issued to employees, directors, or other eligible participants over different grant periods. These unquoted options do not trade on the ASX like ordinary shares and represent contingent equity exposure rather than current shareholdings.
Before this lapse, the total HZRAE options included the 244,080 now expired. After removal, 24,049,941 HZRAE options remain outstanding. The company did not disclose exercise prices, expiry dates, or tranche breakdowns for the remaining options in this update.
Ordinary Shares Remain Steady at 267,847,838
The expiry of 244,080 HZRAE options does not affect the number of ordinary fully paid shares, which remains at 267,847,838 as reported. This figure forms the basis for Hazer’s voting rights and market capitalisation calculations by the ASX.
Since the lapsed options were conditional and unquoted, their cessation neither reduces the share count nor alters shareholder rights but slightly lowers the maximum potential dilution if those options had vested and been exercised.
No Consideration Paid by Hazer Group for Option Expiry
According to the Appendix 3H filing, Hazer Group made no payment related to the cessation of these options. This aligns with standard outcomes where options lapse due to unmet conditions—securities extinguish without cash outflow or share issuance, and holders receive no compensation.
The company indicated no further information beyond the required details was available, suggesting the lapse was a routine administrative event rather than a component of broader remuneration or capital management changes.
Impact of Remaining 24,049,941 HZRAE Options on Dilution
With 24,049,941 HZRAE options still outstanding, investors and analysts should note this pool represents a significant contingent claim on future equity. If all were to vest and be exercised, the share count would increase beyond the current 267,847,838 ordinary shares, though the actual dilution depends on exercise prices, timing, and market conditions.
The announcement did not specify weighted average exercise prices or expiry dates for these options. For detailed terms and vesting schedules, investors should consult Hazer’s Annual Report, remuneration report, or prior Appendix 3G and 2A filings.
Appendix 3H Filing: Purpose and Market Implications
The Appendix 3H form notifies the ASX and market of securities ceasing to be on issue, including option lapses due to unmet conditions. Hazer’s filing on 1 July 2026, the day after the 30 June cessation date, complies with continuous disclosure rules.
While routine, this filing ensures ASX records on issued capital remain accurate. The data reported is used by ASX to calculate Hazer’s market capitalisation and provides transparency to shareholders and the investment community about capital structure changes, however minor.
Hazer Group’s Technology and Commercialisation Overview
Hazer Group develops the proprietary Hazer Process, which uses iron ore as a catalyst to convert natural gas into hydrogen and graphite. The company’s Commercial Demonstration Plant program is a key focus area. The lapse of this relatively small tranche of options does not affect Hazer’s operational plans or technology development timeline.
Investors primarily track milestones related to hydrogen production technology, commercial agreements, and scaling efforts. This capital structure update is unlikely to significantly influence the share price but enhances transparency for market participants assessing equity structure. No immediate share price impact was evident from public information.
Implications of Conditional Rights Lapse on Performance Criteria
The lapse due to unmet or unsatisfiable conditions indicates these were performance-based or conditional options rather than simple time-vesting rights. Although Hazer did not disclose details, such conditions often involve share price targets, operational goals, or continued employment.
The announcement does not elaborate on why conditions were unmet or whether other performance targets remain active. Investors should avoid inferring broader operational or strategic conclusions from this small tranche lapse within Hazer’s overall capital structure.
Important Dates and Figures in the Options Expiry Disclosure
The cessation date is 30 June 2026, coinciding with the Australian financial year-end, a common milestone for incentive arrangements. The update was lodged on 1 July 2026. The lapsed securities total 244,080, all within the HZRAE unquoted option class.
Post-lapse, Hazer reports 267,847,838 ordinary fully paid shares and 24,049,941 unquoted HZRAE options outstanding. The company notes these figures are automatically generated and may not fully reflect current issued capital if other Appendix forms are being processed simultaneously, a standard disclaimer for Appendix 3H filings. No other issued capital changes were disclosed.
Investor Considerations Following the Update
For Hazer investors, the expiry of 244,080 options represents a minor but confirmed adjustment to capital structure. More significant developments will come from progress in hydrogen and graphite production, partnership announcements, funding, or demonstration plant results.
Future relevant disclosures may include Appendix 3G notices for new options or performance rights, Appendix 2A forms for share issuances, or further Appendix 3H filings as other option tranches expire or have conditions tested. No forward guidance on these matters was provided in this update.
